- Home
- PDSB vs IXHL Comparison
PDSB vs IXHL Comparison
Compare PDSB & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDSB
- IXHL
- Stock Information
- Founded
- PDSB 2005
- IXHL 2001
- Country
- PDSB United States
- IXHL Australia
- Employees
- PDSB N/A
- IXHL N/A
- Industry
- PDSB Biotechnology: Pharmaceutical Preparations
- IXHL
- Sector
- PDSB Health Care
- IXHL
- Exchange
- PDSB Nasdaq
- IXHL Nasdaq
- Market Cap
- PDSB 72.2M
- IXHL 78.7M
- IPO Year
- PDSB N/A
- IXHL N/A
- Fundamental
- Price
- PDSB $1.11
- IXHL $0.44
- Analyst Decision
- PDSB Strong Buy
- IXHL
- Analyst Count
- PDSB 2
- IXHL 0
- Target Price
- PDSB $10.00
- IXHL N/A
- AVG Volume (30 Days)
- PDSB 402.8K
- IXHL 243.6M
- Earning Date
- PDSB 08-13-2025
- IXHL 09-29-2025
- Dividend Yield
- PDSB N/A
- IXHL N/A
- EPS Growth
- PDSB N/A
- IXHL N/A
- EPS
- PDSB N/A
- IXHL N/A
- Revenue
- PDSB N/A
- IXHL $98,000.00
- Revenue This Year
- PDSB N/A
- IXHL $2,538.49
- Revenue Next Year
- PDSB N/A
- IXHL $249.95
- P/E Ratio
- PDSB N/A
- IXHL N/A
- Revenue Growth
- PDSB N/A
- IXHL N/A
- 52 Week Low
- PDSB $0.85
- IXHL $0.08
- 52 Week High
- PDSB $4.29
- IXHL $3.12
- Technical
- Relative Strength Index (RSI)
- PDSB 39.41
- IXHL 46.55
- Support Level
- PDSB $1.06
- IXHL $0.34
- Resistance Level
- PDSB $1.15
- IXHL $0.57
- Average True Range (ATR)
- PDSB 0.07
- IXHL 0.22
- MACD
- PDSB 0.01
- IXHL -0.07
- Stochastic Oscillator
- PDSB 36.14
- IXHL 7.73
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.